Take the leap, and lets achieve your weight loss goals together!
One possible explanation is your body adjusting to B12 replenishment
Roughly 20 to 30% of users, particularly those with severe chronic degeneration, report minimal improvement
The prescription peptides semaglutide, liraglutide, and tirzepatide are generally intended for people with a body mass index (BMI) of 30 or higher , or a BMI of 27 or higher with weight-related health conditions such as type 2 diabetes, high blood pressure, or sleep apnea (FDA Wegovy prescribing information)
In trials, it has been shown that when two groups of patients adopt healthy lifestyle changes like eating a healthy diet and routine exercise, the group that receives these types of treatments sees greater results